Letters to the Editor
Unrealistic Estimation of Population Prevalence of Antiphospholipid Antibody–Related Pregnancy Loss: Comment on the Article by Andreoli et al
Version of Record online: 27 MAY 2014
Copyright © 2014 by the American College of Rheumatology
Arthritis Care & Research
Volume 66, Issue 6, page 966, June 2014
How to Cite
Clark, C. A. and Laskin, C. A. (2014), Unrealistic Estimation of Population Prevalence of Antiphospholipid Antibody–Related Pregnancy Loss: Comment on the Article by Andreoli et al. Arthritis Care Res, 66: 966. doi: 10.1002/acr.22273
- Issue online: 27 MAY 2014
- Version of Record online: 27 MAY 2014
- Accepted manuscript online: 24 DEC 2013 07:53AM EST
- 1APS Action.Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res (Hoboken) 2013;65:1869–73., , , , , , on behalf of
- 2Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 2012;64:2311–8., , , , , , et al.
- 3Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 2009;68:1428–32., , , , , , et al.
- 4Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS). Rheumatology (Oxford) 2014;53:275–84., , , , , , et al.